- Salt Dental Partners adds Maryland pediatric dental group
- 9 federal government, policy updates to know
- This population doesn’t know 988 exists: 5 things to know
- 17 dentists making headlines
- Dentistry is 35% consolidated: 7 notes on the state of dental M&A
- North Carolina drops pre-approval requirement for DSO agreements
- Mass General Brigham nurses end walkout: 5 things to know
- Thomas Jefferson University to open 2nd regional medical school campus
- Experity acquires Exdion Healthcare in AI revenue cycle push
- FDA approves 1st on-body cancer drug
- The title CIOs actually want
- The 52 rural emergency hospitals by state
- Virginia system expands rehab care with new hospital
- Ex-ransomware negotiator gets 70 months for BlackCat healthcare attacks
- Minnesota AG secures refunds for patients of dental practice that closed without notice
- 2nd US citizen tests positive for Ebola: 3 outbreak updates
- New Florida ASC expands orthopedic offerings
- Anthropic’s Claude now handles healthcare claims, care management
- MSO acquires 2 physician-owned practices
- Physician among charged in $20M kickback, unnecessary prescription scheme
- Reducing orthopedic coding denials with AI — 4 takeaways
- Weight-Loss Drugs Help, But Exercise Is Still The Key To A Healthier Heart
- Adderall Misuse Falls Sharply Among Young Adults, Study Finds
- Smartphones Can Increase Seniors' Risk Of Depression
- Pro Soccer Players Show Signs Of Shrinking Brains
- A New Option For Long-Term Care Costs
- New KFF Poll Reveals Who Is Most Likely To Endorse Vaccine Myths
- As GOP Cries Fraud, Newsom Backs Medicaid Spending on Housing and Food
- Journalists Discuss Raw-Milk Marketing, Extreme Heat, Opioid Settlement Spending
- 15 states sue US Education Department over mental health cuts
- 23 new behavioral health study findings to know
- Illinois grows certified recovery support workforce 335% since 2022
- New Mexico awards $24.5M for behavioral health expansion
- 38 behavioral health executive moves to know
- Payers are pushing top anesthesiologists out of the insurance model
- Virginia’s largest dental group adds Overjet AI platform
- My Community Dental Centers appoints chief people officer
- Former Illinois dental employee pleads guilty to stealing more than $500K from practice
- CMS’ 2027 rules: Why some specialties are ‘on the outside looking in’
- U of Maryland appoints interim dental school dean
- CMS’ ASC rule: Gains for some, cuts for others
- What leaders need to know about rising mental health leave
- CMS’ next payment move puts spine ASCs in focus
- The functions ASC leaders won’t hand off
- Washington’s noncompete ban: What healthcare employers need to know
- Doctors want wearable data but healthcare isn't ready for it, AMA survey finds
- MaineHealth launches psychiatric nurse practitioner, physician associate fellowship
- California completes statewide behavioral health shift: 3 things to know
- Feds push back HIPAA security rule overhaul to July 2027
- Katie Couric's Memory Loss Scare Puts Rare Brain Condition In Spotlight
- Mild COVID Can Lead To Long-Term Hidden Eye Problems
- Star Padcev-Keytruda combo expands bladder cancer reach with FDA approval, pressuring AstraZeneca
- ACO REACH participants generated nearly $1B in 2024 savings: CMS
- Young people living with PKU take the mic in BioMarin podcast series, TikTok push
- Apollo inks €3B equity deal for stake in Bayer's contraceptives business
- Op-ed: Tackling affordability is a shared responsibility. Here's what hospitals are doing
- Pearl Health banks $110M in fresh funding to build out tech and AI for Medicare providers
- FDA rejects Hengrui, Elevar’s PD-1 liver cancer combo for a 3rd time
- LGBTQ+ People Less Likely To Be Screened For Some Common Cancers
- Smartphone App Uses Voice To Predict Asthma, COPD Flare-Ups
- Seniors Know How Sharp They Are At Any Given Time, Study Finds
- Patients Face A Thicket of Red Tape Trying To Maintain Consistent Health Coverage
- AI Can Detect Previously Invisible MS Scars In The Brain
- A New Option for Long-Term Care Costs
- They Harvest the Nation’s Food, but a New Rule May Strip Them of Health Insurance
- Sanofi snags FDA thumbs up for Sarclisa as 1st cancer drug delivered by on-body injector
- Fierce Pharma Asia—More AZ China deals; Kailera, Hengrui’s oral GLP-1 data; Scrutiny of Chinese trials
- J&J’s Tremfya retakes ad spending throne in June as Haleon tops pharma’s World Cup airings
- Sobi earns top spot in bleeding disorder patient groups' pharma reputation rankings
- South Carolina cites behavioral health facility over missing correction plan
- Former Mayo Clinic research director sues system over alleged retaliation for raising AI practice concerns
- A $10B deal, China trial scrutiny and highlights from ADA 2026
- Memorial Hermann Health Plan winds down commercial coverage
- Remarks at the Society for Corporate Governance Conference
- CVS' Omnicare unit agrees to $440M settlement with DOJ in ongoing fraud case
- GLP-1 Use Hits Record High As Medicare Opens Access To Weight-Loss Drugs
- Beyond Benchmarks: Why Trust Must Be Built into Clinical AI Infrastructure
- Founder of telehealth startup Done sentenced to six years in prison for Adderall fraud scheme
- HHS calls on hospitals to sign 'Make Hospital Food Healthier Pledge'
- Foundation Fights Medical Errors That Claim 200,000 U.S. Lives A Year
- Former exec alleges Alignment Healthcare leaders juiced profits to boost bonuses
- Weekly Rundown: Surgical Safety Technologies rebrands to Aimbient; UC San Diego launches applied health intelligence institute
- In compensation push, HHS gears up to draft COVID vaccine injury table
- AZ, Ionis shares tumble on ATTR-CM trial flop, but analyst flags over-reaction
- Frazier Healthcare Partners to acquire MatrixCare in $490M deal
- New, Highly Accurate Brush Test Can Detect Mouth Cancer Within An Hour
- Innovative Hip Replacement Cuts Post-Surgery Risk Of Dislocation By 70%
- Global Study Finds Kids Worldwide Skipping Fruits And Vegetables
- Ipsen’s Botox rival Dysport charts new horizons with dual phase 3 wins in migraine
- Affordable Care Act Insurers Want More Premium Increases As Enrollment Sags
- My Search for a Psychiatric Bed in an Overburdened Health System
- How Lee Health Turned Language Access into a Strategic Clinical Asset
- Dr. Reddy's presses pause on generic semaglutide supply after flagging API issue
- OpenEvidence launches medical AI copilot feature that grades medical evidence and unveils NewYork-Presbyterian collaboration
- Novo Nordisk asks public to ‘Meet Me in the Middle’ in new obesity experience installation
- BioNTech plots right-sized HER2 ADC launch to ‘build the muscle’ for BMS-partnered bispecific
- Health tech startup Forus inks partnership with GI medical society to improve medication access
- UnitedHealthcare unveils Lifestyle Spending Accounts for employer plans
- FDA hits Lundbeck with untitled letter over efficacy claims on migraine drug Vyepti
- Sanofi floats flu shot marketing pledges to pacify EU antitrust probe
- Tampa General Hospital sues Eli Lilly over pulled 340B discounts
- Viz.ai expands neurodegenerative disease care in new partnership with Cortechs.ai
- Decision readiness is the next AI advantage
- E. Coli Outbreak Prompts Recall Of Frozen Blueberries At Publix
- Drinking Coffee May Lower Your Risk of Liver Disease
- FDA halts release of new drug rejection letters while working to formalize policy
- Mass General Brigham nurses, home care clinicians launch largest healthcare strike in state history
- AI wearables company Vilo launches Signal OS ahead of upcoming smart ring launch
- CureDuchenne lights the candles with DMD public service campaign highlighting birthdays
- Zimmer Biomet to Hire 500 in India as New Bengaluru Technology Centre Drives AI and MedTech Innovation
- Zimmer Biomet to Hire 500 in India as New Bengaluru Technology Centre Drives AI and MedTech Innovation
- AdaptHealth Investigates Data Breach After Social Engineering Attack, Possible Link to ShinyHunters Emerges
- AdaptHealth Investigates Data Breach After Social Engineering Attack, Possible Link to ShinyHunters Emerges
- Rumination Plays Key Role In Caregiver Stress, Study Says
- U.S. Teens Underestimate Risks Of Fentanyl Use, Survey Finds
- Men More Likely To Be Diagnosed With Advanced Cancer
- Copay Assistance Is Meant To Defray Patient Drug Costs. Some Insurers Keep It Instead.
- Training Program Could Ward Off Injuries Among Soccer Girls
- Affordable Care Act Insurers Want More Premium Increases as Enrollment Sags
- Patients Face a Thicket of Red Tape Trying To Maintain Consistent Health Coverage
- Allergan Aesthetics helps map paths for young women in STEM with Girls Inc. event
- Accountability Is Key to Medicaid's Home Care Future
- Clinical Success Is No Longer One Number
- Thousands of Medicare Beneficiaries Thought Their Drug Plan Was Free. Then They Lost It.
- Michigan, Other States See Unusual Spike In Parasite That Causes 'Explosive' Diarrhea
- Statement on the 2026 Regulatory Agenda
- 9 of the Top 10 Pharma Manufacturers Partner with Redi Health to Lead the Next-Generation Patient Experience
- GLP-1 'Secret Shopper' Study Finds Gaps in Online Prescribing
- Applying Agentic AI to Healthcare Delivery: The Key to True Transformation
- Applying Agentic AI to Healthcare Delivery: The Key to True Transformation
- From Compliance to Clinical Action: Fixing the Broken Loop in Post-Market Surveillance
- From Compliance to Clinical Action: Fixing the Broken Loop in Post-Market Surveillance
- Fatty Liver Boosts Odds Of More Deadly Colon Cancer, Study Says
- Weight Loss Surgery Increases Risk Of Alcoholism, Study Says
- IV Vitamin C Might Boost Recuperation Among Trauma Patients
- These Church Members Disagree On Politics. Together They're Wiping Out Medical Debt.
- Exercise Can Ward Off Nicotine Fits, Help Smokers Quit
- Thousands of Medicare Beneficiaries Thought Their Drug Plan Was Free. Then They Lost It.
- Copay Assistance Is Meant To Defray Patient Drug Costs. Some Insurers Keep It Instead.
- New California Law Replaces 'Sell By' Labels On Food Packaging
- Study Raises New Questions About Artificial Sweeteners
- Calling Low-Risk Prostate Cancer Something Else Might Save More Lives, Researchers Argue
- Taking Small Breaks From Sitting Around Can Lower Your Cancer Risk
- Learning Languages Could Net You A Younger Brain, Study Says
- New Disease Threats Follow Trump Administration's Health Program Cuts
- In California Governor’s Race, Voters Face Stark Choice on Immigrant Healthcare
- Regulatory tracker: NICE urges against future Lumakras reimbursement in UK
- Remarks at the Economic Club of New York
- Is Your Organization Ready to Govern AI in Regulatory Affairs?
- Is Your Organization Ready to Govern AI in Regulatory Affairs?
Michigan healthcare freedom community forum
People across the country are reporting illnesses after microdosing psilocybin with mushroom products from Diamond Shruumz of California. Microdosing involves taking very small doses of psychedelics in specially selected mushroom varieties, typically 10% to 20% of recreational doses.
The Michigan Department of Health and Human Services is warning Michigan's trend setters not to eat Diamond-Shruumz products. The U.S. FDA and Centers for Disease Control and Prevention are investigating illnesses associated with Diamond Shruumz-brand microdosing chocolate bars, infused cones, or microdose and macrodose gummies. The products are labeled as having a blend of mushroom varieties like Reishi and Lion's Mane. Their active ingredient, psilocybin is classified as a hallucinogen. Psilocybin used to cause all kinds of strange behaviors 50 years ago when it was a popular street drug.
Psilocybin mushrooms have been decriminalized in Ann Arbor and Detroit.
MDHHS alerting Michigan residents not to eat Diamond Shruumz-brand chocolate bars, cones and gummies during ongoing FDA investigation
By Lynn Sutfin - June 18, 2024LANSING, Mich.-The Michigan Department of Health and Human Services (MDHHS) and the Food and Drug Administration (FDA) are urging Michigan residents not to eat, sell or serve any flavor of Diamond Shruumz-brand Microdosing Chocolate Bars, Infused Cones or Micro Dose and Macro Dose gummies, and instead throw them away. The products are labeled as containing a proprietary blend of mushrooms such as reishi and lion’s mane.
“People in multiple states have become ill after eating these products, reporting a variety of severe symptoms,” said Dr. Natasha Bagdasarian, chief medical executive. “As these products look similar to candy, we urge parents and caregivers to consider discussing this information with their teens even though they are intended for individuals 18 and older. We are advising that everyone avoid these products.”
As of Friday, June 7, the FDA and Centers for Disease Control and Prevention (CDC), in collaboration with America’s Poison Centers and state and local partners, are investigating a series of illnesses associated with eating Diamond Shruumz-brand products. The FDA is working to determine the cause of these illnesses.
A total of 26 illnesses have been reported from 16 states, including Alabama, Arizona, California, Indiana, Kentucky, Maryland, Minnesota, Missouri, Montana, Nevada, New Jersey, New York, North Carolina, Pennsylvania, South Carolina and Tennessee. To date, there are no reported cases in Michigan.
Of those who became ill, 25 people reported seeking medical care, with 16 being hospitalized. No deaths have been reported. People who became ill from eating Diamond Shruumz-brand products reported a variety of severe symptoms including seizures, central nervous system depression (loss of consciousness, confusion, sleepiness), agitation, abnormal heart rates, hyper/hypotension, nausea and vomiting.
Diamond Shruumz-brand products can be purchased online or at a variety of retail locations nationwide, including smoke/vape shops or places that sell hemp-derived or CBD products.
Retailers should not sell or distribute any of these products. Instead, hold these products until further direction is given by the FDA.
Those who become ill after consuming these products should seek medical treatment. They can also call the Poison Help Line at 800-222-1222 to report symptoms and seek information. Callers should let Poison Control know they have recently consumed a Diamond Shruumz-brand chocolate bars, cone or gummies.
Health care providers should report these illnesses to their local health department or the Poison Help Line at 800-222-1222.
MDHHS will continue to monitor incoming information from FDA. Consumers and health care providers can monitor updates about this investigation at Investigation of Illnesses: Diamond Shruumz-Brand Chocolate Bars, Cones, & Gummies (June 2024) | FDA.
Physicians or residents with questions or concerns can contact MDHHS by calling 844-464-7327 or emailing mdhhs-eht@michigan.gov.
FDA is now investigating one death associated with these Diamond Shruumz microdose products, and it is now believed that the toxic agent which caused these sicknesses is muscimol not psilocybin:
https://www.upi.com/Health_News/2024/07/03/Diamond-Shruumz-death/5371719992921/
FDA probing death potentially linked to recalled microdosing candies
By Darryl Coote - July 3, 2024July 3 (UPI) -- Federal food safety officials are investigating a potential death linked to ingesting recalled microdosing chocolates and candies that have sickened dozens of people across the United States.
All Diamond Shruumz-brand chocolates and gummies were recalled late last month over the products containing toxic levels of muscimol, a chemical found in some mushrooms that can cause seizures, involuntary muscle contractions and a loss of consciousness, among other issues.
At least 48 illnesses linked to the edibles have been reported in 24 states as of Monday, the Food and Drug Administration said in an update to the recall on Tuesday.
Twenty-seven of the patients have been hospitalized, it said, adding that there is one potentially associated death under investigation.
American Poison Centers in a statement added that it has received 82 reports of exposure associated with the Diamond Shruumz products, including 48 cases of severe illness, of which all but two sought medical attention.
The FDA said those who became ill after eating Diamond Shruumz-brand products reported a variety of severe symptoms, including seizures, central nervous system depression, agitation, abnormal heart rates, nausea and vomiting.
Diamond Shruumz is instructing its customers to not eat their products amid the investigation. It said in a statment on its website that those who became ill from eating their products had consumed "the entire chocolate bar and some products containing higher levels of muscimol than normal."
The FDA is also recommending not to eat, sell or serve any flavor of Diamond Shruumz-brand chocolate bars, cones or gummies. Those in possession of the recalled products are being instructed to either discard them or return them to the company for a refund.
The products affected by the recall were sold online as well as at retail stores that sell such products, including smoke and vape shops.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.
























